Skip to main content
. 2020 Apr 28;11(17):1515–1530. doi: 10.18632/oncotarget.27566

Figure 8. Survival probability according to the expression of IGF1R mRNA and an additional gene.

Figure 8

Patients expressing low (LOW1) or high (HIGH1) levels of IGF1R and FBLN1 (A), TACC3 (B), PDCD4 (C), or SART1 (D). Patients with high levels of the second gene are denoted HIGH2 and patients with low levels of the second gene are denoted LOW2.